HAP1 and Parkinson disease: In addition, using animal models that mimic the conditions of certain neurodegenerative diseases (e.g., PD, HD, AD), further study is required to elucidate the precise molecular mechanisms underlying the functional aspects of HAP1, which could be employed in prospective therapeutic applications.